| Bioactivity | Vasopressin V2 receptor antagonist 1 (Compound 4g) is a vasopressin V2 receptor (V2R) antagonist with a Ki of 3.8 nM. Vasopressin V2 receptor antagonist 1 can be used for autosomal dominant polycystic kidney disease (ADPKD) research[1]. |
| Target | Ki: 3.8 nM (vasopressin V2 receptor) |
| Name | Vasopressin V2 receptor antagonist 1 |
| CAS | 2648650-50-2 |
| Formula | C33H37ClN4O4 |
| Molar Mass | 589.12 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Haoran Zhang, et al. Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease. J Med Chem. 2022 Apr 1. |
Vasopressin V2 receptor antagonist 1
CAS: 2648650-50-2 F: C33H37ClN4O4 W: 589.12
Vasopressin V2 receptor antagonist 1 (Compound 4g) is a vasopressin V2 receptor (V2R) antagonist with a Ki of 3.8 nM.Vas
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.